Wellorithm Tirzepatide Review: First Price & Renewal Terms
Published by Tirzepatide ReportUpdated
On this page
Injection advertised at $249 first, then $349; monthly and 28-day billing descriptions conflict.
Standout details
- Public injectable first and ongoing charges disclosed
- Initial consultation, shipping and follow-up advertised included
Things to consider
- Pricing says monthly; Terms say every 28 days
- Medication decline may still leave a retained consultation fee
Wellorithm's public pricing page advertises a $249 first payment and $349 ongoing charge for compounded tirzepatide injection. It lists the initial consultation and shipping as included, plus follow-up care. The introductory amount is not the rate to use for continuing treatment.3
Before enrolling, resolve a billing discrepancy: the pricing page describes monthly renewal, while the Terms say fees are collected every 28 days. A four-week cycle and a calendar month do not create the same number of charges over a year.3,4
| Decision | Published condition |
|---|---|
| First injection payment | $249; initial consultation and shipping shown included |
| Ongoing injection charge | $349; pricing says monthly, Terms every 28 days |
| Listed injection doses | 2.5–15 mg; same medication price within listed range |
| Oral/branded options | Separate offer and formulation details required |
Separate the injection quote from the wider menu
The named pricing table covers injectable tirzepatide across its listed 2.5–15 mg dose range and says the medication price is unchanged within that range. The homepage also advertises oral GLP-1 tablets and branded products. That broader menu does not establish that a particular oral tablet contains tirzepatide or carries the injection's price.3,5
A compounded medicine is not an FDA-approved finished drug or interchangeable with a branded product. Read the compounded-tirzepatide legal guide before comparing routes. An oral preparation needs its own ingredient, supply and clinical explanation; a convenient format alone does not establish comparable absorption or outcomes.
What happens at renewal or cancellation?
The pricing page requires cancellation through the account or support at least 48 hours before the next renewal charge. Its monthly description differs from the Terms' 28-day cycle and general email-cancellation wording. Obtain the actual upcoming charge date and the cancellation acknowledgment rather than relying on a monthly anniversary.3,4
The Terms describe processed payments as nonrefundable. The pricing page separately says medication is not charged if the clinician finds treatment inappropriate, but a consultation fee may be retained. Although the initial consultation is shown as included, these documents do not establish an unconditional full cash refund after clinical review.4,3
A conditional guarantee is not a risk-free trial
The Terms describe a possible refund of up to four months of fees for qualifying new users who lose less than 10% after 16 weeks of prescribed adherence. Conditions include no other weight-loss medication in the prior year and weight verification, followed by review. Ask for the complete claim instructions and which fees qualify; do not change or interrupt medication to satisfy a marketing condition.4
| Decision | Published condition |
|---|---|
| Future renewal | Pricing: cancel at least 48 hours before next charge |
| Current payment | Terms describe processed fees as nonrefundable |
| Not prescribed | Medication portion not charged; consultation fee may be retained |
| Weight-loss guarantee | Conditional review after 16 weeks; up to four months of paid fees |
Clinical care, coverage and pharmacy questions
Wellorithm describes itself as a facilitator connecting patients with licensed clinicians. The public pages claim service in all 50 states plus D.C.; individual eligibility and medication access still require clinical review. They also carry a LegitScript certification claim. This review does not independently verify that claim, clinician specialty credentials, or the pharmacy that would dispense your prescription.5,4
For a new preparation, ask the prescribing clinician about its ingredients, concentration and instructions. Our guides to side effects, gallbladder concerns and the thyroid warning provide context for that conversation, rather than instructions for an individualized regimen.
Does the drug work? (Separate from the provider)
Judge the provider on price, oversight and disclosure; judge the molecule on its trials. Tirzepatide's are strong — roughly 15–21% of body weight over 72 weeks in SURMOUNT-11, and better than semaglutide head-to-head2 — but they were run on the brand drug at FDA-approved doses. Our tirzepatide evidence guide has the full picture.
Who may find this useful?
The public injection price is easier to compare than an undisclosed quote, but the billing cycle and retained consultation language deserve clarification first. Compare Brightmeds, Vital Edge and Welling Health on their actual preparation and payment commitments. The provider comparison helps keep a starting charge distinct from a continuing one.
Frequently asked questions
Is $249 Wellorithm’s continuing tirzepatide price?
No. Its named injection pricing lists $249 initially and $349 ongoing. Billing cadence needs clarification because pricing says monthly and Terms say every 28 days.
Does that quote include oral tirzepatide?
It is an injectable tirzepatide quote. A generic oral GLP-1 menu does not establish the ingredients or price of an oral prescription.
Can I cancel just before renewal?
The pricing page requires at least 48 hours before the charge. Confirm the actual processing date and get an acknowledgment.
Is the payment refunded if treatment is declined?
The pricing page says the medication portion is not charged, but a consultation fee may be retained. That is not an unconditional full-refund promise.
References(5)
- Jastreboff AM, Aronne LJ, Ahmad NN, Wharton S, Connery L, Alves B, Kiyosue A, Zhang S, Liu B, Bunck MC, Stefanski A, and the SURMOUNT-1 Investigators (2022). Tirzepatide Once Weekly for the Treatment of Obesity.. New England Journal of Medicine. PMID: 35658024. Read source
- Aronne LJ, Horn DB, le Roux CW, Ho W, Falcon BL, Bays HE, et al. (2025). Tirzepatide as Compared with Semaglutide for the Treatment of Obesity (SURMOUNT-5).. New England Journal of Medicine. PMID: 40353578. Read source
- Wellorithm (2026). Public treatment pricing and billing conditions (accessed October 26, 2026). Official provider public page.
- Wellorithm (2026). Terms and Conditions, public financial and guarantee summary (accessed October 26, 2026). Official provider public page.
- Wellorithm (2026). Official program, route menu and coverage statements (accessed October 26, 2026). Official provider public page.
Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.
Continue reading
Browse provider reviewsBrightmeds Tirzepatide Review: Monthly vs Three-Month Plans
Compare Brightmeds’ qualified B6 tirzepatide offer, three-month bill, five-day authorization capture, renewal cutoff and nonapproval refund.
ReadVital Edge Tirzepatide Review: Recurring Prices & Fee Questions
Compare Vital Edge’s $450 monthly compounded tirzepatide offer, $1,199 three-month bundle and conflicting nonprescription fee language.
ReadIs Compounded Tirzepatide Still Legal in 2026?
Tirzepatide's shortage ended in 2024 and FDA's compounding grace period closed in early 2025. Here's the precise legal status of compounded tirzepatide in 2026.
ReadZepbound Side Effects: Full Breakdown by Frequency
Compare common Zepbound side effects by dose, see trial frequencies and learn which warning signs need prompt medical attention.
ReadTirzepatide and Gallbladder Problems
How often tirzepatide causes gallstones and cholecystitis, why rapid weight loss is part of it, and the red-flag symptoms that need urgent care.
ReadTirzepatide Thyroid Cancer Warning Explained
What tirzepatide's boxed thyroid C-cell tumor warning actually means: verbatim FDA label text, the rat data behind it, and what human evidence shows.
Read